9T7 Stock Overview
Develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Eden Research plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.04 |
| 52 Week High | UK£0.074 |
| 52 Week Low | UK£0.039 |
| Beta | 0.94 |
| 11 Month Change | -13.04% |
| 3 Month Change | -17.53% |
| 1 Year Change | -24.53% |
| 33 Year Change | -50.00% |
| 5 Year Change | n/a |
| Change since IPO | -69.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9T7 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -3.6% | -0.6% | -0.2% |
| 1Y | -24.5% | -0.6% | 7.8% |
Return vs Industry: 9T7 underperformed the German Chemicals industry which returned -1.1% over the past year.
Return vs Market: 9T7 underperformed the German Market which returned 7.9% over the past year.
Price Volatility
| 9T7 volatility | |
|---|---|
| 9T7 Average Weekly Movement | 4.7% |
| Chemicals Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9T7 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 9T7's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 19 | Sean Smith | www.edenresearch.com |
Eden Research plc, together with its subsidiaries, develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications under the Mevalone and Cedroz brand names. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products.
Eden Research plc Fundamentals Summary
| 9T7 fundamental statistics | |
|---|---|
| Market cap | €22.34m |
| Earnings (TTM) | -€1.82m |
| Revenue (TTM) | €4.71m |
4.7x
P/S Ratio-12.3x
P/E RatioIs 9T7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9T7 income statement (TTM) | |
|---|---|
| Revenue | UK£3.94m |
| Cost of Revenue | UK£2.01m |
| Gross Profit | UK£1.93m |
| Other Expenses | UK£3.45m |
| Earnings | -UK£1.52m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0029 |
| Gross Margin | 48.97% |
| Net Profit Margin | -38.70% |
| Debt/Equity Ratio | 0% |
How did 9T7 perform over the long term?
See historical performance and comparison